Search

Your search keyword '"Uchi, H"' showing total 460 results

Search Constraints

Start Over You searched for: Author "Uchi, H" Remove constraint Author: "Uchi, H"
460 results on '"Uchi, H"'

Search Results

1. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

2. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

4. Prognostic impact of the surgical deep margin distance of invasive acral melanoma of the sole: A multi-institutional retrospective study

5. Adjuvant therapy for Asian patients with resected stage III/IV BRAF V600-mutant melanoma with more than 3 years of follow-up: A multicenter retrospective study in Japan

6. A-211 - Adjuvant therapy for Asian patients with resected stage III/IV BRAF V600-mutant melanoma with more than 3 years of follow-up: A multicenter retrospective study in Japan

16. The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: a multicentre prospective observational study

27. Immune checkpoint inhibitor‐induced vitiligo in advanced melanoma could be related to increased levels of CCL19

29. Final results from phase II of combination with canerpaturev (formerly HF10), an oncolytic viral immunotherapy, and ipilimumab in unresectable or metastatic melanoma in second-or later line treatment

31. Immune checkpoint inhibitor‐induced vitiligo in advanced melanoma could be related to increased levels of CCL19.

33. Topline results from phase II of combination treatment with canerpaturev (HF10), an oncolytic viral immunotherapy, and ipilimumab in patients with unresectable or metastatic melanoma after anti-PD-1 therapy

46. 3325 Safety and efficacy of Pembrolizumab (MK-3475) for Japanese patients (pts) with advanced melanoma: Preliminary results from KEYNOTE-041 Phase 1b study

49. PMCID: PMC2626567

Catalog

Books, media, physical & digital resources